AMENDMENT AGREEMENTTechnology Exchange and Cross-License Agreement • October 16th, 2019 • West Pharmaceutical Services Inc • Fabricated rubber products, nec
This Amendment Agreement, is made and entered into this 15th day of October 2019 by and between Daikyo Seiko, Ltd., a corporation organized and existing under the laws of Japan, having a place of business at 1305-1 Kurohakama-Cho, Sano-shi, Tochigi 327-0813 Japan (“Daikyo”) and West Pharmaceutical Services, Inc., a corporation organized under the laws of the Commonwealth of Pennsylvania, U.S.A., having a place of business at 530 Herman O. West Drive, Exton, PA 19341 (“West”).
AMENDED AND RESTATED TECHNOLOGY EXCHANGE AND CROSSLICENSE AGREEMENTTechnology Exchange and Cross-License Agreement • February 28th, 2017 • West Pharmaceutical Services Inc • Fabricated rubber products, nec
THIS AMENDED AND RESTATED TECHNOLOGY EXCHANGE AND CROSSLICENSE AGREEMENT (the “Agreement”), made and entered into this __th day of January, 2017 by and between DAIKYO SEIKO, LTD., a corporation organized and existing under the laws of Japan, having a place of business at 38-2 Sumida 3-Chome, Sumida-Ku, Tokyo 131-0031, Japan (hereinafter, together with its Subsidiaries, referred to as “Daikyo”) and WEST PHARMACEUTICAL SERVICES, INC. (formerly known as THE WEST COMPANY, INCORPORATED), a corporation organized and existing under the laws of the Commonwealth of Pennsylvania, United States of America, having a place of business at 530 Herman O. West Drive, Exton, Pennsylvania 19341, United States of America (hereinafter, “West”). West and Daikyo are sometimes referred to in this Agreement collectively as the “Parties” and each individually as a “Party.”
MATERIAL NOTED WITH [**] IS CONFIDENTIAL AND HAS BEEN DELETED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT, AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSIONTechnology Exchange and Cross-License Agreement • July 31st, 2018 • West Pharmaceutical Services Inc • Fabricated rubber products, nec
This Letter (“Letter”) is intended to memorialize the agreement and understanding between West Pharmaceutical Services, Inc. (“West”) and Daikyo Seiko, Ltd. (“Daikyo”) regarding certain commercial terms relating to the Amended and Restated Technology Exchange and CrossLicense Agreement (the “CrossLicense Agreement”) and the Distributorship Agreement (the “Distributorship Agreement,” and, together with the CrossLicense Agreement, the “Agreements”), each dated effective January 18, 2017.
AMENDED AND RESTATED TECHNOLOGY EXCHANGE AND CROSS LICENSE AGREEMENTTechnology Exchange and Cross License Agreement • March 1st, 2007 • West Pharmaceutical Services Inc • Fabricated rubber products, nec
THIS AMENDED AND RESTATED TECHNOLOGY EXCHANGE AND CROSS LICENSE AGREEMENT (the “Agreement”), made and entered into this day of January, 2007 by and between DAIKYO SEIKO, LTD., a corporation organized and existing under the laws of Japan, having a place of business at 38-2 Sumida 3-Chome, Sumida-Ku, Tokyo 131-0031, Japan (hereinafter, together with its Subsidiaries, referred to as “Daikyo”) and WEST PHARMACEUTICAL SERVICES, INC. (formerly known as THE WEST COMPANY, INCORPORATED), a corporation organized and existing under the laws of the Commonwealth of Pennsylvania, United States of America, having a place of business at 101 Gordon Drive, Lionville, Pennsylvania 19341, United States of America (hereinafter, together with its Subsidiaries, referred to as “West”). West and Daikyo are sometimes referred to in this Agreement collectively as the “Parties” and each individually as a “Party.”
